Related Experiment Videos

[Course and prognosis of primary hypertrophic cardiomyopathies]

La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|December 1, 1983
PubMed

Insights

Familial hypertrophic cardiomyopathy significantly impacts prognosis, with high-risk families experiencing poor outcomes. Echocardiography revealed left ventricular changes, but familial history was the key predictor of survival.

Area of Science:

  • Cardiology
  • Genetics
  • Clinical Medicine

Context:

  • Hypertrophic cardiomyopathy (HCM) is a primary cardiac disorder.
  • Understanding long-term outcomes and prognostic factors is crucial for patient management.

Purpose:

  • To investigate the clinical course and mortality in a cohort of patients with hypertrophic cardiomyopathy.
  • To identify prognostic factors, particularly the role of familial history, in hypertrophic cardiomyopathy.

Summary:

  • A 48-month follow-up of 33 hypertrophic cardiomyopathy patients revealed a 21% 5-year mortality rate, with no sudden deaths observed.
  • Functional deterioration occurred in one-third of patients; echocardiography showed increased left ventricular diastolic diameter and septal thickness.
  • Patients from high-risk familial HCM backgrounds had a significantly poorer prognosis, characterized by early mortality, conduction disturbances, and marked hypertrophy.

Impact:

  • Identifies familial history as a critical independent prognostic factor in hypertrophic cardiomyopathy.
  • Highlights the importance of electrocardiogram and echocardiogram findings in assessing risk within familial HCM.
  • Informs clinical strategies for risk stratification and management of hypertrophic cardiomyopathy patients, especially those with a family history.

Related Concept Videos